Replies to post #545764 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

I already promised to vote with Linda until the end. I understand the concerns of others and will not disagree with them all. If options granted were priced at the 52 week high then I believe there would be greater acceptance. I have always wanted Linda to have leverage with bargaining and she has that when she has ownership. She could help NWBO’s cause at this point by finding a time to purchase on the open market too instead of just growing share count by awards.
The biggest issue is that guidance states no expectation of profitability through this next year and continued dilution. She needs to send a signal to the market that change to that guidance is expected to be seen on the horizon in a reasonable amount of time. If analysts can do this through publicly aquired info and reasonable expectations so can she and the science now formally backs up all the potential. Best wishes.

[HappyLibrarian]

Still voting yes despite the fact that NWBO management are not executing. It will be No at the ASM in 2023 if we’re not in a better spot next year.

[Poor Man -]

I’m waiting too.

What happens over the next couple of weeks will color my opinion, one way or the other.